Novel Non-Invasive Monitoring Parameter in a Hospital Setting
NCT ID: NCT01306201
Last Updated: 2014-08-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2011-02-28
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System
NCT03593603
Bedside Respiratory Patient Monitoring System - Sensor Off Study
NCT02075346
Feasibility Study Of Ambulatory Monitoring System
NCT04959136
Clinical Impact of Non-invasive Hemodynamic Monitoring
NCT02950597
Physiologic Signals and Signatures With the Accuryn™ Monitoring System in Intensive Care Patients
NCT02602782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-patient Volunteers
In-patients from the hospital who choose to participate in the study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Written informed consent from the patient or their legally authorized representative before initiation of any study-related procedures
3. Subjects on general care floor
Exclusion Criteria
2. Abnormalities that may prevent proper application of the device
3. Women who are pregnant or lactating
4. Subjects with significant arrhythmia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sergio Bergese, MD
Role: PRINCIPAL_INVESTIGATOR
The Ohio State Medical Center, Dept of Anesthesia
Robert McIntyre, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado Denver, School of Medicine dept of Surgery Division of GI, Tumor and Endocrine Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Colorado Health Sciences Center (UCHSC)
Denver, Colorado, United States
The Ohio State University Medical Center (OSUMC)
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVMOPR0131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.